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Events related to HCMV infection drive accumulation of functionally enhanced
CD57posNKG2Cpos adapted NK cells. We investigated NK cell adaptation to HCMV
along a proposed continuum progressing from acute activation through maturation
and memory formation towards functional exhaustion. Acute exposure to conditioned
medium collected 24 h after HCMV infection (HCMVsn) increased NK cell cytotoxicity for
all HCMV-seronegative and seropositive donors tested, with mean 38 and 29% boosts
in natural and antibody-dependent cell-mediated cytotoxicity (ADCC), respectively.
Increases in NK cell cytotoxicity were completely abrogated by blocking type I interferon
(IFN) receptors and equivalent responses occurred with exposure to IFN-α2 alone at
the same concentration present in HCMVsn. To study longer term effects of HCMV
infection, we focused on three groups of human immunodeficiency virus (HIV)-infected
subjects distinguished as HCMV-seronegative or HCMV-seropositive with either high
(>20%) or low (<6%) fractions of their NK cells expressing NKG2C. The NK cells of all
three HIV-infected groups responded to HCMVsn and IFN-α2 in a manner similar to the
NK cells of either HCMV-seronegative or seropositive controls. Neither HCMV status, nor
the extent of phenotypic evidence of adaptation to HCMV infection significantly affected
mean levels of ADCC or CD16-mediated NK cell degranulation and IFN-γ production
compared between the HIV-infected groups. Levels of IFN-γ production correlated
significantly with the fraction of NK cells lacking FcεRIγ (FcRγ), but not with the fraction
of NK cells expressing NKG2C. There was negligible expression of exhaustion markers
Lag-3 and PD-1 on NK cells in any of the groups and no significant difference between
groups in the fraction of NK cells expressing Tim-3. The fraction of NK cells expressing
Tim-3 was unaffected by CD16 stimulation. Relative to the total NK cell population,
responses of Tim-3-expressing cells to CD16 stimulation were variably compromised in
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HCMV seronegative and seropositive groups. In general, NK cell function in response to
signaling through CD16 was well preserved in HIV infection and although HCMV had a
clear effect on NK cell FcRγ and NKG2C expression, there was little evidence that the
level of adaptation to HCMV infection affected CD16-dependent NK cell signaling in HIV
infection.
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INTRODUCTION
Natural killer (NK) cells provide defense against malignancy and
infection by recognizing certain alterations in affected cells and
responding accordingly. Activation of NK cells against altered
host cells is regulated by integration of positive and negative
signals received through members of a relatively small set of
germ-line encoded receptors. While NK cells recognize altered
host cells and mediate effector functions without prior exposure
to the altered cells, NK cell functional competence depends
upon previous selective engagement of an inhibitory NK cell
receptor with a class I human histocompatibility-linked antigen
(HLA) (1). This developmental education process enables NK
cells to mediate cytotoxicity and/or produce cytokines when
encountering altered host cells, while ensuring appropriate levels
of self-tolerance (2–5). It also illustrates that NK cell function is
not constitutive upon lineage determination, but dependent upon
subsequent relay of specific signals. Selective NK cell education
at this developmental stage raises the possibility of further
maturation within select subsets under conditions associated
with infections or malignancy. Such NK cell maturation clearly
takes place in murine cytomegalovirus (MCMV) infection. In
this setting, cytokine production and specific receptor ligand
interactions between Ly49H and MCMV m157 drive a subset of
NK cells expressing the Ly49H activating receptor to selectively
expand, persist at elevated levels and provide protection against
subsequent MCMV infection (6–11).
The NK cell response to MCMV infection is the prototype
system within which elements required to generate memory
NK cells were first identified (12–17). Infection with human
(H)CMV drives selective expansion of NK cells expressing
the C-type lectin-like activating receptor NKG2C, prompting
speculation that NKG2C on human NK cells functions in an
analogous way to Ly49H on murine NK cells (18–21). In
several HCMV-infected cell culture systems, selective expansion
of NKG2C-expressing NK cells depends upon the presence of
certain cytokines and interaction between NKG2C and HLA-E
complexed with particular peptides (22, 23). Peptides derived
from the HCMV UL40 protein enable selective proliferation of
NKG2C-expressing NK cells, including those from HCMV naïve
individuals (24). The NKG2C-expressing NK cells expanded
in vivo or in vitro by exposure to HCMV acquire phenotypic
changes that reflect an increased capacity for effector functions
(25–27). This differentiation produces CD57pos NK cells with
increased CD16 expression, lower levels of the associated
FcεRIγ (FcRγ) adaptor protein, reduced natural cytotoxicity
receptor (NCR) expression, and epigenetic changes increasing
the accessibility of cytokine promoter regions (25, 26, 28, 29).
The CD57/NKG2C-expressing NK cells are reportedly more
responsive to stimulation through CD16, at least in terms of
antibody-dependent cytokine production (25–27).
Aging, and various forms of immunological stress, including
congenital, iatrogenic, and HIV infection, exacerbate HCMV-
driven expansion of NKG2C-expressing NK cells (21, 30–
34). It is common for HIV/HCMV co-infected individuals to
have large NK cell fractions expressing CD57 and NKG2C,
within which limitations to NK cell adaptation imposed by
terminal differentiation or exhaustion might be evident (34).
Therefore, to assess NK cell function along a phenotypic
spectrum of adaptation to HCMV infection, we studied healthy
controls and HIV-infected individuals displaying varying degrees
of NK cell adaptation. This included HCMV-infected and
seronegative controls, an HIV-infected HCMV-seronegative
group, an HIV/HCMV co-infected group with small fractions of
NKG2Cpos NK cells and an HIV/HCMV co-infected group with
large fractions of NKG2Cpos NK cells. Functional assessment
began with exposure of NK cells from HCMV-seronegative
controls to HCMV-related cytokines and extended across a wide
range of NK cell exposure and adaption to HCMV infection, as
indicated by the accumulated fractions of phenotypically adapted
NK cells.
MATERIALS AND METHODS
Study Subjects and Sample Collection
This study was carried out in accordance with the
recommendations of the Canadian Tri-Council Policy Statement:
Ethical Conduct for Research Involving Humans. The protocol
was approved by the Health Research Ethics Authority of
Newfoundland and Labrador, Canada. All subjects gave written
informed consent in accordance with the Declaration of Helsinki.
Whole blood was collected with informed consent from healthy
donors and peripheral blood mononuclear cells (PBMC) isolated
by Ficoll-Paque (VWR, Mississauga, ON, Canada) density
gradient centrifugation were suspended in lymphocyte medium
consisting of RPMI-1640 supplemented with 10% fetal calf serum
(FCS), 200 IU/mL penicillin/streptomycin (P/S), 1% 1MHEPES,
1% L-glutamine (all from Invitrogen, Carlsbad, CA, USA) and
2.0 × 10−5 M 2-mercaptoethanol (Sigma-Aldrich, St. Louis,
MO, USA). Individuals infected with HIV recruited through the
Newfoundland and Labrador Provincial HIV Clinic provided
informed consent for whole blood collection, immunological
studies, and researcher access to medical laboratory records.
Freshly isolated PBMC were resuspended in freezing medium
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composed of lymphocyte medium supplemented to 20% FCS
with 10% dimethyl sulfoxide and cooled at 1◦C/min overnight to
−80◦C. Frozen PBMC were then maintained in liquid nitrogen
until analysis. Cryopreserved PBMC were recovered overnight
in lymphocyte medium at 37◦C, 5% CO2. Humoral and CD8
pos
T cell responses against CMV were measured previously as
described and data included with general characteristics of the
HIV-infected study subjects (34, 35).
Generation of HCMVsn
MRC-5 cells (from Dr. Jules Doré, Memorial University of
Newfoundland, St. John’s, NL, Canada) were seeded at 1.25
× 105 cells per well in a 24-well plate and grown in DMEM
supplemented with 10% FCS, 1% L-glutamine, 1% P/S, and
1mM sodium pyruvate (Invitrogen) at 37◦C with 5% CO2.
Forty-eight hours after seeding, MRC-5 cells were infected with
either HCMV AD169 from Dr. Karen Biron through the NIH
AIDS Reagent Program (NIAID, NIH) at multiplicity of infection
(MOI) 0.025 for 1 h or a recombinant vaccinia virus expressing
β-galactosidase (vSC8) at MOI 0.2, from Dr. Bernie Moss
through the NIH AIDS Reagent Program or left untreated (36).
Conditioned medium from uninfected (CONsn) and AD169-
infected (HCMVsn) MRC-5 cells was harvested and medium
replaced in 24 h increments post infection for a total of 120 h.
Conditioned medium from vSC8-infected MRC-5 cells (vSC8sn)
was harvested and medium replaced in 24 h increments post
infection for a total of 72 h. Supernatants were clarified for
10min at 400 g to remove cell debris, frozen at −80◦C in
single-use aliquots and recovered on ice. Inactivated HCMVsn
was generated by collecting conditioned medium from MRC-
5 cells that were exposed to the same amount of ultraviolet
(UV)-irradiated AD169 (41 watts for 1 h at 30 cm).
Cytotoxicity and Redirected Lysis Assays
K562 (ATCC R© CCL 243TM), P815 (ATCC R© TIB-64TM), and
HLA-B27-transfected C1R (C1R-B27; Dr. Kelly McDonald,
University of Manitoba, Winnipeg, MB, Canada) cell lines
were propagated in lymphocyte medium at 37◦C with 5%
CO2 and maintained in log phase for
51Cr labeling and
cytotoxicity assays. K562, C1R-B27, or P815 cells were labeled
for 90min with 100 µCi Na512 CrO4 (PerkinElmer, Akron, OH,
USA). C1R-B27 cells were incubated 30min with 1µg/mL
monoclonal antibody (mAb) against pan HLA-I (W6/32,
ATCC R© HB-95
TM
) to sensitize cells to antibody-dependent
cellular cytotoxicity (ADCC). For interferon (IFN)-α/β receptor
blocking experiments, PBMC were pretreated 30min with
5µg/mL of mAb (clone MMHAR-2) against the IFN-α/β
receptor chain 2 (IFNAR) prior to their addition in a
cytotoxicity assay as described (37). When indicated, purified
active recombinant human IFN-α2 (US Biological, Salem, MA,
USA) was used at a final concentration of 20 pg/mL. Receptor-
triggered cytotoxicity was measured by adding 3µg/mL soluble
IgG isotype control (Ag8) or mAb (clones in parentheses) against
human NKp30 (210845), NKG2C (134591), or NKG2D (149810)
from R&D Systems (Minneapolis, MN, USA) and NKp44 (9E2)
or NKp46 (P44-8) fromBioLegend (SanDiego, CA, USA). PBMC
were incubated in microtiter plates in a final volume of 300
µL for 5 h with 5 × 103 51Cr-labeled K562, C1R-B27, or P815
target cells/well at various effector to target (E:T) ratios with
either CONsn, vSC8sn or HCMVsn at a final dilution of 1 in
5. 51Cr release was measured in 125 µL supernatants collected
from each well on aWallac 1480Wizard gamma counter. Control
wells for spontaneous lysis contained target cells in medium
alone while target cells in maximum lysis wells were treated with
1N HCl. Percent specific lysis was calculated by (experimental
51Cr release – spontaneous 51Cr release)/(maximum 51Cr release
– spontaneous 51Cr release)× 100.
Macromolecular Clearance of Conditioned
Media
Intact HCMV particles were cleared from conditioned media by
treating CONsn or HCMVsn with 0.06µg/mL monoclonal anti-
gB (Dr. Lucy Rasmussen, NIH AIDS Reagent Program) for 2 h at
4◦C in a tube rotator followed by 30min incubation with 4× 106
sheep anti-mouse IgGDynabeads R© (ThermoFisher) permilliliter
of conditioned media. Beads and virus particles were pelleted for
1min at 1,000 g after which time supernatants were decanted and
stored at−70◦C for functional experiments. To remove insoluble
materials from conditionedmedia, samples were ultracentrifuged
using a Sorvall TH-641 rotor at 100,000 g for 16 h at 4◦C.
Multiplex Array
Concentrations of cytokines and chemokines within culture
medium collected from MRC-5 cells untreated or infected
with AD169 or vSC8 (see above) were measured by Milliplex
(Millipore, Merck KGaA, Darmstadt, Germany) according to the
manufacturer instructions and analyzed on the BioPlex-200 (Bio-
Rad, Mississauga, ON, Canada). Samples were run in duplicate
and incubated overnight to improve the sensitivity of detection
as previously described (38).
Flow Cytometry
Human PBMC were stained using directly conjugated mAb
against human CD3 (BW264/56), CD56 (REA196), CD57
(TB03), from Miltenyi Biotec (San Diego, CA, USA), Tim-3
(F38-2E2) from BioLegend and NKG2C (134591) from R&D
Systems. Cells were stimulated with 1 µg anti-CD16 mAb
(3G8; BioLegend) per 106 PBMC and prepared for intracellular
staining by adding brefeldin A (Sigma-Aldrich) 1 h after the
start of incubation to a final concentration of 10µg/mL and
continuing the incubation for an additional 4 h. NK cell
degranulation was detected by introducing directly conjugated
anti-CD107a mAb (H4A3; BioLegend) at a 0.25 µg per 106
PBMC at the time of brefeldin A addition. Cells were fixed
and permeabilized after 5 h incubation using the Inside Stain
Kit (Miltenyi Biotec) as per manufacturer’s instructions and
then stained with directly conjugated polyclonal Ab against
human FcRγ from MilliporeSigma (Burlington, MA, USA) and
anti-human IFN-γ mAb (4S.B3) from eBioscience (San Diego,
CA, USA). Non-viable cells were excluded by fixable live/dead
stain (Invitrogen) as per manufacturer’s instructions. Data were
acquired using a MoFlo Astrios EQ flow cytometer and data
analyses and illustration performed using Kaluza software (both
Beckman Coulter, Brea, CA, USA).
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Statistical Analysis
Statistical analyses were performed using GraphPad Prism
software version 5 with two-sided p< 0.05 considered significant.
Normality of data distributions were assessed with Kolmogorov–
Smirnov, Shapiro–Wilk and D’Agostino and Pearson tests.
Student’s paired or unpaired t-tests were used for group
comparisons when data were normally distributed and non-
parametric Wilcoxon paired signed-rank test or Mann–Whitney
U-tests used otherwise as appropriate.
RESULTS
Soluble Factors Released Early in HCMV
Infection Augment NK Cell Cytotoxicity
Natural killer cells are considered important effectors during
herpesvirus infections. To examine how NK cells respond
to factors released early in HCMV infection, we collected
supernatant from uninfected (CONsn) and AD169-infected
(HCMVsn) MRC-5 fibroblasts over 24 h intervals up to 120 h
post infection. Supernatant was collected from vSC8-infected
(vSC8sn) MRC-5 fibroblasts over 24 h intervals up to 72 h post
infection. We then exposed NK cells to these supernatants in
the presence of K562 target cells in 5 h 51Cr release assays to
assess the effects of acute exposure on NK cell cytotoxicity.
The vSC8sn collected from any of the three time points had
no effect on NK cell cytotoxicity against K562 cells (data not
shown, n = 3) compared to CONsn. In contrast, HCMVsn
collected within the first 24 h after infection increased NK cell
target killing by 50% relative to cytotoxicity in the presence of
CONsn (Figure 1A). While this property of HCMVsn persisted
up to 48 h post infection with conditioned media collected
over a cumulative 48 h (data not shown), its production
peaked during the first 24 h of infection as exposure to
HCMVsn collected between 24 and 48 h post infection had
little effect on NK cell activity (Figure 1A). Increased NK
cell cytotoxicity following exposure to HCMVsn collected at
24 h occurred for all 12 donors tested, with a mean 38%
boost in natural cytotoxicity (Figure 1B) and 29% increase in
NK cell ADCC (Figure 1C). An equal number of HCMV-
seropositive and seronegative donors, differentiated by symbol
shading, are shown in Figure 1, with no apparent differences
in responsiveness to stimulation with HCMVsn related to
previous HCMV exposure. Factor(s) present in HCMVsn
and primarily produced the first 24 h after infection cause a
rapid significant increase in NK cell natural cytotoxicity and
ADCC.
HCMVsn Augments Cytotoxicity Triggered
Through Multiple NK Cell Activating
Receptors
As HCMVsn increased both NK cell natural cytotoxicity
and CD16-dependent responses, we investigated the effect of
HCMVsn on cytotoxicity through other common NK cell
activating receptors. We probed NKG2C, NKG2D, NKp30,
NKp44, and NKp46 using a redirected lysis assay in which
murine FcR-expressing P815 cells orient mAb specific for
particular activating receptors to enable selective NK cell
activation. A representative summary of target cell lysis by
natural cytotoxicity, ADCC and redirected killing through
individual activating receptors is shown in Figure 2A. Using
an IgG isotype control antibody, there was little P815 cell lysis
and no significant difference from control conditions when
HCMVsn was present during the 5 h assay (Figure 2B). By
introducing mAb against individual NK cell activating receptors,
we observed that HCMVsn significantly increased P815 cell
lysis through NKG2C (Figure 2C), NKG2D (Figure 2D), and
the NCRs NKp30 and NKp46, but not NKp44 (Figures 2E–G).
These data demonstrate that HCMVsn sensitizes NK cells for
cytotoxicity triggered through CD16, most NCRs and through
activating C-type lectin-like receptors. As with the increased
killing of K562 and ADCC, there was no apparent difference
in the responses of NK cells from HCMV-seropositive and
seronegative subjects discriminated on the graphs by different
symbols.
IFN-α Produced During HCMV Infection
Enhances NK Cytotoxicity
While a cell-free component of HCMVsn increased NK cell
pan cytotoxic function, it was unclear whether this effect was
mediated through macromolecular interactions with different
NK cell activating receptors or by cytokines. Augmented
NK cell cytotoxicity was sustained following clearance of
macromolecular material by HCMVsn ultracentrifugation
(Figure 3A) or following selective removal of HCMV particles
by magnetic beads and a mAb against HCMV glycoprotein
gB (Figure 3B). Inactivating HCMV before its addition to
MRC-5 cells (UV HCMVsn) prevented the increase in NK cell
cytotoxicity observed with replication competent HCMVsn
(Figure 3C), indicating that a soluble product from HCMV-
infected cells increases NK cell cytotoxicity through multiple
activating receptors.
To identify potential factors present in HCMVsn that increase
NK cell cytotoxicity, we measured analytes using a bead-
based multiplex assay. Luminex analysis of HCMVsn revealed
increased concentrations of monocyte chemoattractant protein
and macrophage colony stimulating factor (data not shown),
IL-6, IL-8, IL-15, IFN-α2, and IFN-β compared to CONsn
(Figure 3D right and left panels). Modest concentrations of
biologically active IL-15 (10 pg/mL; data not shown) were also
detected. Analysis of vSC8sn revealed increased concentrations
of IL-6, IL-8, and IL-15 with a marginal increase in IFN-β
at the 48 h time point. Blocking stimulation through IFNAR
alone with a specific mAb fully prevented any increase in
NK cell activity in response to HCMVsn (Figure 3E). This
blocking effect was specific for type I IFNs as increased
NK cell activity in response to IL-2 was maintained in the
presence of the same amount of mAb against IFNAR (data
not shown). HCMV-infected fibroblasts produced both IFN-
α2 and IFN-β (80 and 450 pg/mL, respectively, data not
shown) during the first 24 h of infection. To determine whether
the amount of IFN-α2 detected in HCMVsn during the first
24 h of infection could alone mediate the same increases
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FIGURE 1 | Effect of HCMVsn on NK cell cytotoxic responses of healthy controls. (A) CONsn or HCMVsn was collected at 24 h intervals up to 120 h post infection,
diluted 1:5 and effects on NK cytotoxicity tested using fresh PBMC from healthy controls in 5 h 51Cr release assays. NK cell cytotoxicity with either CONsn or
HCMVsn against (B) K562 cells (n = 12) or (C) anti-HLA-I-coated C1R-B27 cells (n = 10) was measured over 5 h at E:T 60:1. Subjects seropositive for HCMV are
represented with filled black circles or yellow squares half-shaded black. Error bars in (A) represent mean ± standard deviation (SD) of two replicates, (B) mean ± SD
with Student’s paired t-test used for comparisons between conditions and (C) median with interquartile range (IQR) with Wilcoxon signed-rank test used to estimate
the probability of a difference between conditions. Percent cytotoxicity increase in (A) was calculated as [(% specific lysis with HCMVsn – % specific lysis with
CONsn)/% specific lysis with CONsn] × 100 from paired data performed in duplicate.
in NK cell cytotoxicity as HCMVsn, we compared NK cell
natural and antibody-dependent cytotoxic activity in response to
HCMVsn or purified recombinant IFN-α2. Exposure to similar
concentrations of IFN-α2 (20 pg/mL) as added with HCMVsn
diluted 1 in 5 in 51Cr release assays increased NK cell natural
cytotoxicity (Figure 3F) and ADCC (Figure 3G) to an extent
indistinguishable from the increases mediated by HCMVsn.
Thus, stimulation through the type I IFN receptor alone
rapidly sensitized NK cells to natural and antibody-dependent
cytotoxicity and the acute increase in natural cytotoxicity and
ADCC for NK cells from healthy controls mediated by soluble
factors in HCMVsn is replicated with IFN-α2 alone at levels
present in HCMVsn.
The increase in NK cell cytotoxicity following exposure
to HCMVsn occurred with both HCMVpos and HCMVneg
healthy donors indicating that the NK cell response to cytokines
produced by HCMV-infected cells is independent of previous
sensitization from in vivo HCMV infection (Figures 1, 2).
To investigate such responses along a continuum of NK
cell adaptation to HCMV infection, we tested effects of
HCMVsn and IFN-α2 with HIV-infected subjects whose NK
cells spanned a broad range of adaptation in response to HCMV
infection.
HCMVsn and IFN-α2 Enhance NK Cell
ADCC in HIV-Infected Individuals
After establishing that NK cells from healthy donors respond
rapidly, robustly and independent of HCMV serostatus to IFN-
α2 produced by HCMV-infected fibroblasts, we next studied
NK cell responses from HCMVneg and HCMVpos individuals
within an HIV-infected study cohort. Since adapted NK
cells exhibit enhanced CD16-mediated effector responses, we
measured the impact of HCMVsn and IFN-α2 on NK cell
ADCC in HIV infection and compared baseline levels of ADCC
between three groups reflecting a broad range of NK cell
adaptation to HCMV infection. General characteristics of the
individuals and comparisons between HCMV-seronegative and
seropositive groups are shown in Table 1. We selected three
groups of HIV-infected study subjects, two distinguished by
high (>20%) vs. low (<6%) fractions of NK cells expressing
NKG2C and a third distinguished by seronegative HCMV
status (Table 1). Nine of the 28 age- and sex-matched HIV-
infected individuals selected for this study were HCMV-
seronegative. The efficacy of antiretroviral therapy was roughly
equivalent between groups as indicated by undetectable HIV
viral loads (<50 copies HIV RNA/mL plasma). Neither nadir,
nor current CD4pos T cell counts, indicative of past disease
progression and present immunological status, respectively,
differed significantly between groups. All donors had a robust
fraction of mature (CD57pos) NK cells, independent of HCMV
status or fraction of their NK cells expressing NKG2C. However,
the percentage of NK cells expressing CD57 was significantly
lower in the NKG2Clo group than in the NKG2Chi group
(p= 0.0133, Mann–Whitney U-test), suggesting lesser overall
NK cell maturation in the NKG2Clo group (Table 1). There
were no significant differences in either humoral (anti-CMV IgG
levels) or cellular (% CD8pos T cells specific for CMV pp65 and
IE-1) immune responses against CMV between the HCMVpos
groups with high or low fractions of NK cells expressing
NKG2C.
The HCMVneg individuals and those with high or low
fractions of NKG2C-expressing NK cells were pooled to assess
responsiveness of NK cells from HCMVneg and HCMVpos
subjects infected with HIV to HCMV-related cytokines. The
mean increase in ADCC mediated by HCMV-related cytokines
(24%) was similar to that seen in the HIV-naïve group and was
not significantly different from the mean 14% increase elicited by
recombinant IFN-α2 alone (Figure 4A). Neither HIV-infection
nor adaptation to HCMV infection appeared to affect NK cell
responsiveness with acute exposure to IFN-α2. Median levels of
NK cell ADCC measured from HIV-infected individuals were
also unrelated to either HCMV serostatus or NK cell adaptation
to HCMV infection (Figure 4B). Adaptation to HCMV infection
had little effect on the capacity of NK cells from HIV-infected
individuals to respond to acute IFN-α2 exposure or to mediate
ADCC.
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FIGURE 2 | Effect of HCMVsn on NK cell cytotoxicity directed through different receptors. (A) Natural cytotoxicity (K562 cells), and redirected lysis of P815 cells in the
presence of NK receptor-specific mAb for a representative subject with or without HCMVsn was measured over 5 h. Error bars represent mean ± standard error of the
mean with three replicates. Redirected P815 cell lysis was measured at E:T 30:1 with 3µg/mL (B) isotype control (IC), (C) anti-NKG2C, (D) anti-NKG2D, (E)
anti-NKp30, (F) anti-NKp44, or (G) anti-NKp46 mAbs. Assays represented in plots (B–G) were performed in triplicate for 7–9 individuals. Subjects seropositive for
HCMV are represented with filled black circles or yellow squares half-shaded black. Error bars for isotype control and anti-NKp46 plots represent median with IQR and
the probability of a difference between conditions was assessed by Wilcoxon signed-rank test. All other bars represent mean ± SD with comparison between
conditions by Student’s paired t-test.
Long Term Adaptation of NK Cells From
HIV-Infected Individuals to HCMV Infection
To study longer term effects of HCMV infection, including the
possibility of progression to exhaustion, we compared features of
the three groups of HIV-infected subjects distinguished by high
vs. low NK cell fractions expressing NKG2C or by seronegative
HCMV status (Table 1). The flow cytometry gating strategy
for a representative HIV/HCMV co-infected donor is shown
in Figure 5A. Median NKG2C expression levels were similar
between the HCMVneg and NKG2Clo groups (Figure 5B),
however, the influence of adaptation to HCMV within the
NKG2Clo group was evident from the lower mean fraction of
NK cells expressing FcRγ (Figure 5C) and strong correlation
between loss of FcRγ expression and level of HCMV-specific
antibodies (Spearman r = 0.5539, p = 0.0022 Table 1). Loss of
the FcRγ signaling adaptor subunit in parallel with expansion
of NK cells expressing NKG2C is apparent from the progressive
increase in percentage of FcRγneg NK cells across the three
groups and by the significant correlation between fractions
of NK cells expressing NKG2C and fractions lacking FcRγ
(Figures 5C, D). Despite this general progression and significant
correlation, three HIV-infected individuals within the NKG2Clo
group with <6% of their NK cells expressing NKG2C and
>50% lacking FcRγ illustrate that loss of FcRγ by NK cells
is not inexorably linked to NKG2C expression (Figure 5C,
Table 1).
Preservation of NK Cell
Antibody-Dependent Effector Functions in
HIV-Infected Subjects
An association between NK cell adaptation to HCMV
infection and increased capacity for antibody-dependent
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FIGURE 3 | Identification of cytokines produced by HCMV-infected MRC-5 cells. The effect of HCMVsn on NK cell cytotoxicity was assessed by 51Cr release using
K562 target cells at E:T 30:1 after removal (A) of insoluble materials by ultracentrifugation (HCMVsn UCF) or (B) HCMV particles with monoclonal anti-gB and goat
anti-mouse IgG Dynabeads. (C) Ultraviolet-light inactivated virus was used to generate UV HCMVsn and its effect on NK cell cytotoxicity was measured as above (n =
6). Subjects seropositive for HCMV are represented with filled black circles or triangles and yellow squares half-shaded black. Error bars in (A,C) represent mean ± SD
with conditions compared using Student’s paired t-test and (B) median with IQR and conditions compared by Wilcoxon signed-rank test. (D) Luminex analysis of
HCMVsn collected at 24 h intervals over 120 h (left panel) or vSC8sn collected at 24 h intervals over 72 h (right panel) compared IL-6, IL-8, IL-15, IL-12p70, IFN-α2,
and IFN-β concentrations. Data shown represents fold change in the amount of cytokine detected in HCMVsn or vSC8sn/CONsn performed in duplicate ± SD. (E)
PBMC (n = 5) were pretreated with 5µg/ml of IgG control or anti-IFNAR before incubation with CONsn or HCMVsn in a 5 h 51Cr release assay. Bars represent mean
± SD performed in duplicate with conditions compared using Student’s paired t-test. The effect of 20 pg/mL recombinant IFN-α2 was compared to that of HCMVsn
on NK cell (F) natural cytotoxicity and (G) ADCC (n = 8). Bars represent mean ± SD, performed in triplicate with conditions compared using Student’s paired t-test.
Data in (A–C,E–G) represent percent cytotoxicity increase or percent specific lysis, respectively, calculated as described in the legend for Figure 1.
IFN-γ production was previously reported (39, 40).
Since ADCC responses against antibody-coated C1R-
B27 cells by the HIV-infected subjects measured by 51Cr
release assays were similar, irrespective of HCMV status
and NKG2C expression levels, we next measured and
compared IFN-γ production and CD107a expression
of NK cells in the three groups in response to CD16
stimulation.
Activation through CD16 induced robust NK cell IFN-γ
responses (representative plots in Figure 6A), the magnitude
of which directly correlated with the percentage of NK
cells lacking FcRγ (Figure 6B). This is exemplified by one
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TABLE 1 | HIV-infected study subject characteristics.
Age range Sex α-CMV
IgG (OD)*
CMV-specific
CD8pos T cells
(%)
†
CD4pos
T cells‡
Nadir§ HIV
VL‖
NKG2Cpos
NK cells
(%)
FcRγneg
NK cells
(%)
CD57pos
NK cells
(%)
Tim-3pos
NKcells (%)
HCMVneg 44–56 7♂
2♀
0.054 0.1 714 51 1.4 1.03 3.95 22.54 2.36
0.055 0.1 640 286 2.3 2.68 22.19 11.89 8.22
0.036 0.0 1320 81 1.3 2.84 7.07 54.79 5.31
0.044 0.0 700 324 1.3 2.35 12.32 20.77 8.28
0.029 0.1 966 154 1.3 2.99 7.63 57.54 0.53
0.048 0.0 429 85 1.3 3.70 9.43 55.95 5.55
0.080 0.0 667 154 1.3 4.41 20.72 54.68 4.95
0.027 0.0 912 658 1.3 3.31 7.35 50.74 6.56
0 0.0 833 490 1.3 2.37 30.07 61.86 0.40
x¯ 51.8 0.040 0.0 798 254 1.4 2.85 13.41 43.42 4.68
HCMVpos
NKG2Clo
33–58 7♂
2♀
1.265 4.7 1085 314 1.3 1.96 61.14 41.84 3.58
1.418 2.2 638 192 1.7 4.76 55.75 26.74 4.2
1.324 5.0 946 245 1.3 1.46 12.60 54.96 6.61
0.686 1.0 1026 229 1.3 0.30 6.74 37.88 3.8
1.047 2.2 492 93 1.3 4.72 12.76 26.46 6.69
1.567 1.6 624 6 1.3 0.47 25.97 32.04 5.64
0.846 2.2 957 192 1.6 5.92 26.07 39.83 8.56
0.767 0.7 725 660 1.3 1.72 19.23 58.60 8.37
0.670 1.9 903 169 1.3 1.81 71.70 10.50 6.25
x¯ 47.8 1.070 2.4 822 233 1.4 2.57 32.44 36.54 5.97
HCMVpos
NKG2Chi
36–60 8♂
2♀
1.552 1.6 588 25 1.3 46.25 46.25 42.97 6.82
0.897 0.2 570 206 1.6 44.21 86.07 79.36 4.25
1.489 1.0 285 16 ND 50.81 80.85 45.91 7.03
0.993 0.8 760 380 1.3 41.07 47.98 68.19 8.34
0.810 0.6 780 245 1.3 27.05 77.83 54.35 3.24
0.723 0.4 760 63 1.3 24.4 30.63 40.37 9.68
1.769 0.2 1254 276 1.3 27.61 44.42 39.01 7.02
0.579 7.2 792 108 1.3 46.48 60.22 61.39 2.74
1.275 2.3 748 407 1.3 42.66 42.07 66.01 6.05
1.676 4.0 455 416 1.3 42.85 57.09 52.93 5.53
x¯ 48.1 1.180 1.9 699 214 1.33 39.34 57.34 55.05 6.07
*Optical density (OD) by ELISA measuring α-CMV IgG (plasma diluted 1:500) against lysate from HCMV AD169-infected MRC-5 cells (34).
†
Percentages of CMV-specific CD8pos T cells identified by stimulation with overlapping peptides from CMV pp65 and IE-1 proteins followed by detection of intracellular IFN-γ (34, 35).
‡Number of CD4pos T cells per microliter of peripheral blood at time of testing.
§Lowest recorded CD4pos T cell count per microliter of peripheral blood.
‖Log10 copies HIV RNA per milliliter of plasma at time of testing.
ND, not determined.
subject with over 80% NK cells lacking FcRγ and over
40% producing IFN-γ in response to stimulation through
CD16 (Figure 6B). In contrast, we found no significant
correlation between the fraction of FcRγneg NK cells and
fraction of NK cells expressing NKG2C or between NK
cell FcRγ expression and degranulation, as measured by
CD107a expression following CD16 stimulation. When
we compared CD16-stimulated degranulation and IFN-γ
production between HCMVneg, NKG2Clo, and NKG2Chi
groups, there were no significant differences in percentages of
CD107apos NK cells (Figure 6C), IFN-γpos NK cells (Figure 6D)
or polyfunctional NK cells doubly positive for CD107a and
IFN-γ (Figure 6E). All groups’ NK cells responded robustly to
CD16 stimulation, irrespective of NKG2C expression levels or
HCMV serostatus, illustrating HCMV-independent preservation
of antibody-dependent NK cell responses in chronic HIV
infection.
To assess NK cell progression toward an exhausted
phenotype, expression of PD-1, LAG-3, and Tim-3 was
assessed on NK cells within the three defined groups.
Levels of PD-1 and LAG-3 were low to undetectable on
NK cells (data not shown), but substantial fractions of
NK cells within each group expressed Tim-3 (Figure 5A,
Table 1).
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FIGURE 4 | Effects of HCMVsn and IFN-α2 on ADCC of NK cells from HIV-infected individuals. (A) ADCC within the HIV-infected group was measured in 51Cr release
assays over 5 h at E:T 30:1 in the presence of a 1:5 dilution of HCMVsn or 20 pg/mL recombinant human IFN-α2 as previously described and compared to untreated
conditions (n = 21). (B) Baseline ADCC levels were compared between the three groups of HIV-infected individuals distinguished by HCMV serostatus and fraction of
NK cells expressing NKG2C. Error bars represent median with IQR, performed in duplicate with conditions compared using Wilcoxon signed-rank test.
FIGURE 5 | Phenotypic characterization of NK cells from HIV-infected individuals with different levels of adaptation to HCMV infection. To identify the NK cell
population, (A) PBMC were selected and dead cells excluded. NK cells were identified by expression of CD56 in the absence of CD3 and further characterized for
percentage expressing NKG2C, CD57, Tim-3, and FcRγ in a representative plot. Summary plots depict the percentage of total NK cells that are positive for (B)
NKG2C or (C) FcRγ. Individual donors were grouped based on HCMV serostatus (HCMVneg) and fraction of NK cells expressing NKG2C within the HCMVpos donors
(NKG2Clo or NKG2Chi). Correlation between NK cell NKG2C and FcRγ expression was assessed in (D) with Spearman correlation coefficient (r) calculated and the
probability of a significant correlation (p) shown on the graph. Error bars in (B) for the HCMVneg group represent median with IQR, while all others represent mean ±
SD. Groups were compared using Mann–Whitney U-tests.
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FIGURE 6 | Effects of NK adaptation to HCMV infection on CD16-dependent degranulation and IFN-γ production in HIV infection. NK cells were untreated or
stimulated for 5 h with anti-CD16 (3G8) after which time IFN-γ production and CD107a expression was assessed by flow cytometry. Representative plots with gating
on total NK cells as in Figure 5 show (A) IFN-γ and CD107a expression on resting (left panel) and CD16-stimulated NK cells (right panel). For each donor, percent NK
cells positive for (B) IFN-γ was plotted vs. percent FcRγneg cells and correlation between the magnitude of NK cell IFN-γ responses and fraction of NK cells lacking
FcRγ was assessed using Pearson correlation coefficient (r) with the probability (p) of a significant correlation shown on the graph. The percentage of NK cells positive
for (C) CD107a, (D) IFN-γ, or (E) doubly positive for CD107a and IFN-γ was measured for each donor (n = 7–10) and grouped as in Figure 5. Error bars represent
mean ± SD where data was normally distributed and median with IQR in all other cases.
Antibody-Dependent Effector Functions of
Tim-3pos NK Cells From HIV-Infected
Subjects
As Tim-3 receptors were expressed at levels readily measurable
by flow cytometry, we compared the extent of Tim-3 expression
on NK cells within the three groups and the functional capacity
of the Tim-3pos subset. The percentage of NK cells expressing
Tim-3 ranged from 0 to 10%, did not differ significantly between
groups (Table 1) and CD16-stimulation did not induce NK cell
Tim-3 expression (data not shown). The percentage of Tim-
3pos NK cells responding to CD16 stimulation with IFN-γ
expression, CD107a expression, or both, was compared with
the percentage of total NK cells responding likewise. Tim-
3-expressing NK cells from HCMVneg HIV-infected donors
degranulated to a lesser extent than the general NK cell
population but showed no apparent deficit in IFN-γ production
(Figure 7A). In contrast, Tim-3pos NK cells from HIV/HCMV
co-infected donors responded similarly to the general NK
cell population in terms of CD107a expression, but were less
likely to produce IFN-γ in response to stimulation through
CD16 (Figure 7B). The significance of Tim-3 expression on
NK cells may vary with respect to the function studied
and extent of adaptation to HCMV infection. There were
no significant differences between HCMVneg, NKG2Clo, and
NKG2Chi groups in percentage of Tim-3pos NK cells expressing
CD107a or IFN-γ in response to stimulation through CD16
Figure 7C.
DISCUSSION
Expansion of NKG2C-expressing NK cells was initially reported
in the context of multiple viral infections, including hepatitis
C virus, HIV, chikungunya, and hantavirus, but subsequent
investigation identified HCMV infection as the critical common
denominator (41, 42). While only a small fraction of NK
cells in healthy HCMV-seronegative individuals usually express
NKG2C, HCMV infection triggers various levels of adaptation,
resulting in more than 80% NKG2Cpos NK cells in extreme
cases (34). Therefore, we envision a continuum of NK cell
adaptation to HCMV infection through which naïve NK cells
respond to initial HCMV exposure, differentiate into mature
effector cells and, under the influence of time, repeated exposure
and other factors, progress toward terminal differentiation.
In this study, we investigated NK cell function along this
proposed continuum, beginning with exposure of naïve NK
cells to cytokines present during acute HCMV infection and
encompassing responses of NK cell populations reflecting
broadly different degrees of adaptation to HCMV. To compare
the quality of NK cell responses across the spectrum of adaptation
to HCMV, we selected subjects from a well characterized
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FIGURE 7 | CD16-dependent degranulation and IFN-γ production by Tim-3pos NK cells in HIV infection. The percentage of cells expressing CD107a (left panels) or
IFN-γ (right panels) within either the total or Tim-3pos NK cell populations after CD16 stimulation was measured based on the gating strategy shown in Figure 5 and
contrasted between (A) HCMVneg (n = 9) and (B) HCMVpos (n = 15–19) and between the (C) HCMVneg, NKG2Clo, and NKG2Chi HIV-infected study groups. Error
bars in (A) represent mean ± SD and comparison between conditions carried out with Student’s paired t-test. Bars in (B) represent mean ± SD and Student’s paired
t-test performed (left panel) or median with IQR with significance calculated by Wilcoxon signed-rank test (right panel). Error bars in (C) represent mean ± SD where
data was normally distributed and median with IQR in all other cases.
cohort of HIV-infected individuals within which there are
HCMV-seronegative subjects, HCMV-seropositive subjects with
small fractions of NKG2Cpos NK cells and HCMV-seropositive
subjects with large fractions of NKG2Cpos NK cells (34).
This chosen study group allowed comparison of CD16-
dependent NK cell functions over a broad range of phenotypic
adaptation to HCMV infection in the context of co-infection
with HIV.
Acute exposure to conditioned media collected from HCMV-
infected fibroblasts elevated NK cell cytotoxicity through
NCRs, C-type lectin receptors and CD16, irrespective of NK
cell donor HIV or HCMV status. While enhanced antibody-
dependent effector function through CD16 is a characteristic
of the NKG2Cpos NK cells adapted to HCMV infection, these
adapted NK cells are also reported to downregulate NCRs
(18). Downregulation of NCRs is a common consequence of
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chronic viral infection, likely involving physical interactions and
chronic cytokine stimulation. In combination with additional
stimulation, pan increases in NCR-mediated cytotoxicity
stimulated by HCMV-related cytokines may lend toward
phenotypic alterations over periods of prolonged cytokine
exposure. While IL-6, IL-8, and IL-15 were present in HCMVsn
together with type I IFNs, these same cytokines were also elevated
in vSC8sn, which did not increase NK cell cytotoxicity, indicating
that at most, they may play some ancillary role in acute activation
of NK cell cytotoxicity. Our data indicate that IFN-α2 is sufficient
to effect the same increases in NK cell cytotoxicity as mediated by
conditioned media from HCMV-infected fibroblasts. There were
no significant differences between NK cell responses to purified
recombinant IFN-α2 vs. HCMVsn in either the healthy control
cohort or HIV-infected group. As type I IFNs are produced in
a variety of viral infections that do not lead to expansion of
NKG2Cpos NK cells, it is unlikely that acute exposure to IFN-α2
alone contributes significantly to the NK cell adaptation specific
to HCMV infection. Infection with HCMV in vivo may result in
different patterns of type I IFN production and cellular responses
dependent upon the local environment, cell type infected and
virus characteristics.
By selecting three groups of individuals with comparable
features of HIV infection, we were able to focus on the impact
that different levels of adaptation to HCMV infection have onNK
cell phenotype and function in this setting. Two HCMV-infected
groups were selected for high vs. low levels of NKG2C expression,
with the low NKG2C expression group indistinguishable from
the HCMVneg group in this respect. Although one donor
within the NKG2Clo category had a CD57pos NK cell fraction
comparable to those in the NKG2Chi group, the rest had low to
moderate (10–27%) CD57pos NK cell fractions. The influence of
HCMV infection on FcRγ downregulation was themost apparent
phenotypic aspect, displaying a clear hierarchy; the HCMVneg
group had the lowest fraction of FcRγneg NK cells followed
sequentially by the NKG2Clo andNKG2Chi groups. A disconnect
betweenNKG2C expression and loss of FcRγwas notable in three
individuals with <6% NKG2Cpos and more than 50% FcRγneg
NK cells. Although it involves only three individuals in this case,
the disconnect has also been noted in studies of NKG2Cnull
cohorts, where lack of NKG2C had little effect on HCMV-driven
NK cell maturation (43–45). Despite these three outliers, there
was a strong overall correlation between the fraction of NK cells
expressing NKG2C and fraction of FcRγneg NK cells. Thus, NK
cells from these outliers may express features similar to those
from NKG2Cnull subjects (45). Evidently, loss of FcRγ is a more
consistent indicator of NK cell differentiation and adaptation in
response to HCMV infection than NKG2C expression.
Adaptation to HCMV infection through NKG2Cpos NK cell
expansion and loss of FcRγ reportedly produces an NK cell
population with superior CD16-mediated effector functions (25–
27). In the context of our HIV-infected study cohort, there
was no evidence of this in cytotoxicity assays against antibody-
coated target cells. Although we saw significant correlation
between the size of the IFN-γ response and fraction of NK
cells lacking FcRγ, there was also no significant difference
between the groups in terms of the mean fraction of NK cells
producing IFN-γ in response to CD16 signaling. Despite low
levels of NKG2CposFcRγneg NK cells, the HCMVneg group had
CD16-mediated responses equally as robust as the other groups
and the HCMVposNKG2Clo group displayed no functional
deficits relative to either of the other groups. This finding
is somewhat unexpected in light of epigenetic remodeling of
the NK cell IFNG locus following HCMV infection, with the
adapted NK cell population reportedly exhibiting enhanced IFN-
γ responses (39, 40). Whether this apparent discrepancy reflects
the impact of HIV infection, different experimental methodology
or peculiarities of the limited number of subjects tested in this
study remains to be determined.
The extent of NK cell degranulation following CD16-
stimulation was also not significantly different between groups
and in contrast to IFN-γ production, we noted no significant
correlation between the magnitude of CD107a responses and
fraction of NK cells lacking FcRγ. Polyfunctional NK cell
responses, indicated by dual expression of IFN-γ and CD107a
also did not differ between groups. Thus, our data suggest
that in the context of HIV infection, phenotypic evidence of
NK cell adaptation to HCMV infection does not equate with
superior CD16-mediated effector functions. The finding here
most consistent with previous studies using donors not infected
with HIV was the correlation between CD16-triggered IFN-γ
production and loss of FcRγ adaptor subunits (25, 26). Whether
loss of FcRγ is a marker for other alterations or its absence
plays a direct role in enhanced signaling through CD16, this
aspect of NK cell adaptation to HCMV infection appears to be
maintained in HIV infection. We saw no relationship between
FcRγ expression and either ADCC measured by 51Cr release or
CD16-triggered degranulation, lending credence to speculation
that NK cell adaptation to HCMV affects CD16-mediated
cytokine production more so than it affects cytotoxicity.
To investigate NK cell progression toward terminal
differentiation, we assessed PD-1, Lag-3 and Tim-3 expression.
We detected little to no PD-1 or Lag-3 in any of the three
groups, yet a significant fraction of NK cells expressed Tim-3.
Tim-3 expression levels did not differ between groups and were
unaffected by CD16 stimulation. Although recent reports suggest
enhanced function of Tim-3pos NK cells, we observed functional
deficits in degranulation and IFN-γ production in the HCMVneg
and HCMVpos groups, respectively, relative to the general NK
cell population (46). Although significant, these deficits were
relatively slight and based on the responses of a small group of
HIV-infected individuals. Further study of the role Tim-3 has on
NK cell functions in different settings is warranted.
In summary, type I IFNs produced during in vitro HCMV
infection of fibroblasts increased NK cell cytotoxicity through
multiple receptors. This increase in NK cytotoxicity occurred
with NK cells fromHCMV-seronegative and seropositive healthy
controls. In the HIV-infected subjects, we saw a similar increase
in ADCC that was unrelated to HCMV status or extent
of NK cell adaptation to HCMV infection. Cytokine and
degranulation responses mediated through CD16 were well
preserved in the HIV-infected individuals we studied, again
unrelated to their HCMV status. Despite an inverse correlation
overall between NK cell CD16-triggered IFN-γ production and
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FcRγ expression, the HCMVneg, HIV-infected subject group did
not have a significantly lesser IFN-γ response than either of
the groups with higher fractions of FcRγneg NK cells. There
was no evidence that NK cell adaptation to HCMV affects
degranulation responses or cytotoxicity triggered through CD16
in HIV infection. While these findings suggest that HCMV-
related NK cell adaptation has different or lesser functional
consequence in HIV infection, the clear effect of HCMV on FcRγ
expression and the extreme levels of adaptation observed in terms
of NKG2C expression illustrate the same selectivity operating
with increased pressure. Immunological pressures associated
with HIV infection may preserve or enhance NK cell function
through compensatory pathways distinct from HCMV-driven
adaptation.
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